Third Harmonic Bio announced positive Phase 1 results for THB335, an oral KIT inhibitor, paving the way for a...

In this conversation with Dominique Demolle, CEO of Cognivia, we explore the power of understanding patient psychology to enhance...

Pfizer and Astellas announced updated results from the Phase 3 EV-302 trial, showing sustained overall survival (OS) and progression-free...

Achieve Life Sciences announced positive safety results from the second review of their ongoing ORCA-OL trial for cytisinicline, a...

Ashvattha Therapeutics announced positive Phase 2 trial data for its subcutaneously administered nanomedicine, Migaldendranib (MGB), designed to treat retinal...

Radiopharm Theranostics announced positive results from a study using a novel imaging approach with RAD 101 (18F-Pivalate) to detect...

In the dynamic world of clinical trials, Yunu is revolutionizing imaging services with cutting-edge technology and strategic partnerships. Jeffrey...

eGenesis successfully transplanted a genetically modified pig kidney into a second patient with end-stage kidney disease. The procedure, part...

Cyclo Therapeutics presented data from its pivotal Phase 3 TransportNPC™ trial of Trappsol® Cyclo™ for Niemann-Pick Disease Type C1...

AIM ImmunoTech Inc. is initiating a plan to further develop Ampligen as a vaccine adjuvant for avian influenza. The...